Pretransplant cancer in kidney recipients in relation to recurrent and de novo cancer incidence posttransplantation and implications for graft and patient survival

Background.Whether kidney transplant recipients who were treated for a malignant tumor before transplantation are at an increased risk of developing a tumor posttransplantation has not been adequately quantified and characterized.Methods.We studied more than 270 000 patients on whom pretransplant an

Saved in:
Bibliographic Details
Main Authors: Unterrainer, Christian (Author) , Opelz, Gerhard (Author) , Döhler, Bernd (Author) , Süsal, Caner (Author)
Format: Article (Journal)
Language:English
Published: March 2019
In: Transplantation
Year: 2019, Volume: 103, Issue: 3, Pages: 581-587
ISSN:1534-6080
DOI:10.1097/TP.0000000000002459
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/TP.0000000000002459
Verlag, lizenzpflichtig, Volltext: insights.ovid.com
Get full text
Author Notes:Christian Unterrainer, Gerhard Opelz, Bernd Döhler, Caner Süsal
Description
Summary:Background.Whether kidney transplant recipients who were treated for a malignant tumor before transplantation are at an increased risk of developing a tumor posttransplantation has not been adequately quantified and characterized.Methods.We studied more than 270 000 patients on whom pretransplant an
Item Description:Gesehen am 09.03.2020
Physical Description:Online Resource
ISSN:1534-6080
DOI:10.1097/TP.0000000000002459